Thus a possible mechanism could be that in ERα-positive breast cancer cells, E2 decreases the expression level of ERα, but at the same time, increases its nuclear translocation, resulting in an increased level of ERα in the nucleus and hence enhancement in ERα activity [51]. Here, ESR1 is linked to breast cancer.